A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A
Open Access
- 23 August 2018
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 16 (11) , 2184-2195
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 21 references indexed in Scilit:
- Guidelines for the management of hemophiliaHaemophilia, 2012
- Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia modelBlood, 2012
- Hemostatic properties of a TFPI antibodyThrombosis Research, 2012
- Tissue factor pathway inhibitor: structure-functionFrontiers in Bioscience-Landmark, 2012
- Meeting unmet needs in inhibitor patientsHaemophilia, 2010
- Venous access in haemophilic children: choice and managementHaemophilia, 2010
- Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needsHaemophilia, 2009
- Tissue Factor and Factor VIIa as Therapeutic Targets in Disorders of HemostasisAnnual Review of Medicine, 2008
- Identifying and overcoming barriers to prophylaxis in the management of haemophiliaHaemophilia, 2007
- Barriers to compliance with prophylaxis therapy in haemophiliaHaemophilia, 2001